A. Pál

[The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].

G. Blaskó, J. Hamvas, J. Tarján, 1999, Orvosi hetilap.

Should soluble CD40 ligand be measured from serum or plasma samples?

D. Bereczki, J. Balla, M. T. Magyar, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Differences in the platelet proaggregatory activity of immune complexes isolated from patients with myocardial infarction or pulmonary cancer.

L. M. Srivastava, G. Blaskó, N. Das, 1999, Platelets.

Serum Levels of Platelet Released CD40 Ligand Are Increased in Early Onset Occlusive Carotid Artery Disease

L. Csiba, G. Blaskó, D. Bereczki, 2006, Disease markers.